Authors
Jessica Zucman-Rossi,
Primary liver cancer (PLC) is the third leading cause of cancer death, accounting for 830,180 deaths worldwide in 2020. PLCs are mainly composed of hepatocellular carcinoma (HCC, ∼85%) and intrahepatic cholangiocarcinoma (iCCA, ∼10%).
HCC is PLC characterized by hepatocellular differentiation; in contrast, CCAs are biliary differentiated tumors. HCC and iCCA define a spectrum of PLCs that also include mixed tumors (combined HCC-CCA [cHCC-CCA]), which are much more uncommon (∼1%). They are defined by the presence of HCC and CCA areas in various proportions, as well as, in some cases, the presence of transitional features within the same tumor.
Other publications
01 Feb 2026
Authors :
Hercent Agathe,
Julien Masliah-Planchon,
David Cohen,
Rémy Nicolle,
Jean-Yves Scoazec,
Ruszniewski Philippe,
Ivan Bièche,
Mestier Louis De,
Anne Couvelard,
Jérome Cros,
19 Dec 2025
Authors :
Hercent Agathe,
Julien Masliah‐Planchon,
David Cohen,
Rémy Nicolle,
Jean‐Yves Scoazec,
Ruszniewski Philippe,
Ivan Bièche,
Mestier Louis De,
Anne Couvelard,
Jérome Cros,
Predictive value of metabolic state on PanNET response to mTOR inhibitors
Endocr Relat Cancer
28 Sep 2025
Authors :
Jérome Cros,
Margot Bucau,
Matthieu Tihy,
Maxime Palazzo,
Pierre Bourgoin,
Anais Chassac,
Miguel Albuquerque,
Alain Sauvanet,
Safi Dokmak,
Burgio Marco Dioguardi,
Valérie Paradis,
Olivia Hentic,
Ruszniewski Philippe,
Mestier Louis De,
Vinciane Rebours,
Anne Couvelard,
Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations
Scientific Reports
21 Aug 2025
Authors :
Paulina Dragan,
Valérie Gratio,
Thierry Voisin,
Alain Couvineau,
Dorota Latek,